News Finding: "One of the advantages of DPP-4 inhibition as a treatment for diabetes is the very low risk of hypoglycaemia.
Paper Finding: [ Fig.
News Context: Diabetes drug could protect against low blood sugar
  
  "If these inhibitors also prove effective in humans against low blood sugar, then this supports the idea that the area of application of these drugs could be broadened to include persons with diabetes that is difficult to control and suffer from frequent hypoglycaemias", said Siri Malmgren, a researcher at Lund University. "One of the advantages of DPP-4 inhibition as a treatment for diabetes is the very low risk of hypoglycaemia. Through Dr Malmgren's important work, a fundamental new principle for this has been identified.
Paper Context: It was found that GIR was lowered by 89.0± 3.1% in mice given vildagliptin compared with control mice (3.9 ± 1.1 vs 35.1 ± 3.1 μmol kg [ Fig. 1c] ).